Jasper Therapeutics, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.37 | $-0.24 | +35.1% | Beat |
| Q12026 FY2026 | $-0.46 | $-0.38 | +17.4% | Beat |
| Q42025 FY2025 | $-0.79 | $-0.32 | +59.5% | Beat |
| Q12026 FY2026 | $-0.79 | — | — | Miss |
Back to JSPR overview · JSPR holders · JSPR KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.